Qu Biologics has added Karn Manhas, Founder and CEO of Terramera, to its Board of Directors. Qu Biologics is a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore innate immune function. Manhas brings a wealth of experience and knowledge in government, business development and as a clean technology […]